FNJ has received Grant/Research support from the Brain and Behaviour Research Institute, the National Health and Medical Research Council (NHMRC), Australian Rotary Health, the Geelong Medical Research Foundation, the Ian Potter Foundation, Eli Lilly, Meat and Livestock Australia, Woolworths Limited, Fernwood Foundation, Wilson Foundation, The A2 Milk Company, Be Fit Foods, and The University of Melbourne and has received speakers honoraria from Sanofi-Synthelabo, Janssen Cilag, Servier, Pfizer, Health Ed, Network Nutrition, Angelini Farmaceutica, Eli Lilly and Metagenics
The optimal pH range for AHK-Cu formulations falls between 5 and 7
The results from the second semaglutide 7.2 mg phase III trial, STEP UP T2D, in adults with type 2 diabetes and obesity are expected within the next few months
Ibutamoren does not appear to increase cortisol levels, but it can also lead to hyperprolactinemia